GE HealthCare Technologies (STU:L0T) Stock Based Compensation: €132 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:L0T GE HealthCare Technologies Inc STU:L0T
71 GF Score
Price €60.46
GF Value €72.66
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is GE HealthCare Technologies Stock Based Compensation?

GE HealthCare Technologies STU:L0T -3.45% 71 Stock Based Compensation is €132 Mil as of Jun. 2026. GuruFocus rates STU:L0T with a GF Score™ of 71/100 and a GF Value™ of €72.66 (Modestly Undervalued). The stock has 3 warning signs investors should review.

GE HealthCare Technologies's Stock Based Compensation for the three months ended in Jun. 2026 was €39 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2026 was €132 Mil.

GE HealthCare Technologies Stock Based Compensation Related Terms

GE HealthCare Technologies Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for GE HealthCare Technologies's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GE HealthCare Technologies Stock Based Compensation Chart

GE HealthCare Technologies Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial 67.26 63.25 104.54 119.38 111.02

GE HealthCare Technologies Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.48 32.38 30.74 30.28 39.06
STU:L0T
71GF Score
GE HealthCare Technologies Inc STU:L0T
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GE HealthCare Technologies Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €132 Mil.

What does a Stock Based Compensation of €132 Mil mean?
GE HealthCare Technologies (STU:L0T) has a Stock Based Compensation of €132 Mil as of Jun. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for GE HealthCare Technologies and its competitors.
Is GE HealthCare Technologies' Stock Based Compensation too high?
GE HealthCare Technologies' current Stock Based Compensation is €132 Mil. Overall, GE HealthCare Technologies has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GE HealthCare Technologies' Stock Based Compensation compare to DXCM and STE?
GE HealthCare Technologies' Stock Based Compensation of €132 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Devices & Instruments company?
A good Stock Based Compensation depends on the Medical Devices & Instruments industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for GE HealthCare Technologies and its competitors. GE HealthCare Technologies's current Stock Based Compensation is €132 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GE HealthCare Technologies stock overvalued right now?
Based on GuruFocus' analysis, GE HealthCare Technologies (STU:L0T) is currently considered Modestly Undervalued. The stock's GF Value™ is €72.66, compared to a current price of €60.46 — trading 16.8% below its estimated fair value. The current Stock Based Compensation is €132 Mil. GE HealthCare Technologies' overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For GE HealthCare Technologies (STU:L0T), the current Stock Based Compensation is €132 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GE HealthCare Technologies (STU:L0T) Overvalued in 2026?

Based on GuruFocus' analysis, GE HealthCare Technologies stock appears to be undervalued. The current stock price of €60.46 is trading 16.8% below its estimated GF Value™ of €72.66. GuruFocus considers GE HealthCare Technologies to be Modestly Undervalued.

Key valuation signals for STU:L0T:

  • Stock Based Compensation: €132 Mil
  • GF Value™: €72.66 vs. price of €60.46 (16.8% below fair value)
  • GF Score™: 71/100 with 3 warning signs

No single metric tells the full story. See the STU:L0T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GE HealthCare Technologies Business Description

Address 500 West Monroe Street, Chicago, IL, USA, 60661
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
71GF Score

Get the complete analysis for STU:L0T

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€60.46
Price
€72.66
GF Value